351 related articles for article (PubMed ID: 20231449)
1. Identification of hepatoprotective flavonolignans from silymarin.
Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.
Polyak SJ; Morishima C; Shuhart MC; Wang CC; Liu Y; Lee DY
Gastroenterology; 2007 May; 132(5):1925-36. PubMed ID: 17484885
[TBL] [Abstract][Full Text] [Related]
3. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
4. Influence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblasts.
Svobodová A; Walterová D; Psotová J
Burns; 2006 Dec; 32(8):973-9. PubMed ID: 17011711
[TBL] [Abstract][Full Text] [Related]
5. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
[TBL] [Abstract][Full Text] [Related]
6. Silymarin for HCV infection.
Polyak SJ; Oberlies NH; Pécheur EI; Dahari H; Ferenci P; Pawlotsky JM
Antivir Ther; 2013; 18(2):141-7. PubMed ID: 23011959
[TBL] [Abstract][Full Text] [Related]
7. Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
Wagoner J; Morishima C; Graf TN; Oberlies NH; Teissier E; Pécheur EI; Tavis JE; Polyak SJ
PLoS One; 2011 Jan; 6(1):e16464. PubMed ID: 21297992
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity.
Schrieber SJ; Wen Z; Vourvahis M; Smith PC; Fried MW; Kashuba AD; Hawke RL
Drug Metab Dispos; 2008 Sep; 36(9):1909-16. PubMed ID: 18566043
[TBL] [Abstract][Full Text] [Related]
10. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Ahmed-Belkacem A; Ahnou N; Barbotte L; Wychowski C; Pallier C; Brillet R; Pohl RT; Pawlotsky JM
Gastroenterology; 2010 Mar; 138(3):1112-22. PubMed ID: 19962982
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioactivity of silybin B methylation products.
Sy-Cordero AA; Graf TN; Runyon SP; Wani MC; Kroll DJ; Agarwal R; Brantley SJ; Paine MF; Polyak SJ; Oberlies NH
Bioorg Med Chem; 2013 Feb; 21(3):742-7. PubMed ID: 23260576
[TBL] [Abstract][Full Text] [Related]
12. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation.
Plísková M; Vondrácek J; Kren V; Gazák R; Sedmera P; Walterová D; Psotová J; Simánek V; Machala M
Toxicology; 2005 Nov; 215(1-2):80-9. PubMed ID: 16076518
[TBL] [Abstract][Full Text] [Related]
13. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
14. Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-kappaB activity and IL-2 production.
Gharagozloo M; Velardi E; Bruscoli S; Agostini M; Di Sante M; Donato V; Amirghofran Z; Riccardi C
Pharmacol Res; 2010 May; 61(5):405-9. PubMed ID: 20056147
[TBL] [Abstract][Full Text] [Related]
15. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
Chlopcíková S; Psotová J; Miketová P; Simánek V
Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver.
Das SK; Vasudevan DM
Indian J Biochem Biophys; 2006 Oct; 43(5):306-11. PubMed ID: 17133738
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways.
Saliou C; Rihn B; Cillard J; Okamoto T; Packer L
FEBS Lett; 1998 Nov; 440(1-2):8-12. PubMed ID: 9862414
[TBL] [Abstract][Full Text] [Related]
18. A sensitive LC-MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma.
Brinda BJ; Zhu HJ; Markowitz JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():1-9. PubMed ID: 22766231
[TBL] [Abstract][Full Text] [Related]
19. Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.
Deep G; Gangar SC; Rajamanickam S; Raina K; Gu M; Agarwal C; Oberlies NH; Agarwal R
PLoS One; 2012; 7(4):e34630. PubMed ID: 22514647
[TBL] [Abstract][Full Text] [Related]
20. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention.
Graf TN; Wani MC; Agarwal R; Kroll DJ; Oberlies NH
Planta Med; 2007 Nov; 73(14):1495-501. PubMed ID: 17948171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
